Endovascular therapy with covered stent for aortoiliac occlusive disease:clinical effect in 20 patients
10.3969/j.issn.1008-794X.2018.02.005
- VernacularTitle:覆膜支架腔内介入治疗主髂动脉闭塞20例临床效果
- Author:
Qihong NI
1
;
Jiaquan CHEN
;
Lei LU
;
Xiangjiang GUO
;
Lan ZHANG
;
Meng YE
Author Information
1. 200127,上海交通大学医学院附属仁济医院血管外科
- Keywords:
covered stent implantation;
endovascular therapy;
aortoiliac occlusive disease
- From:Journal of Interventional Radiology
2018;27(2):118-121
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical effect of endovascular therapy with covered stent in treating aortoiliac occlusive disease. Methods The clinical data of 20 patients with aortoiliac occlusive disease, who received endovascular therapy with covered stent during the period from January 2014 to December 2016, were collected. According to Rutherford standard of clinical symptom classification, gradeⅢ, grade Ⅳ and grade V were seen in 9, 7 and 4 patients respectively. Based on the Trans-Atlantic Society Coalition (TASC) treatment guidelines Ⅱ classification, B type, C type and D type were observed in 4, 7 and 9 patients respectively. The postoperative primary patency and secondary patency of the stent as well as the clinical efficacy were analyzed. Results Endovascular treatment was successfully accomplished in all 20 patients. After the treatment, the clinical symptoms were significantly relieved. Two patients developed complications (10％). One patient developed thrombus at the distal end of stent, which was improved after thrombolytic therapy. Another patient developed hematoma at puncture site, which was absorbed after conservative therapy. No perioperative death occurred. The patients were followed up for 5-37 months, with a mean of (17±10) months. The primary patency rate was 95％ and the secondary patency rate was 100％. Conclusion For the treatment of aortoiliac occlusive disease, endovascular therapy with covered stent has excellent clinical efficacy.
